Cost-effectiveness analysis in comparing alginate silver dressing with silver zinc sulfadiazine cream in the treatment of pressure ulcers
Apirag Chuangsuwanich, Peerasak Chortrakarnkij, Jupaporn Kangwanpoom, Apirag Chuangsuwanich, Peerasak Chortrakarnkij, Jupaporn Kangwanpoom
Abstract
Background: The treatment of pressure ulcers is complicated, given the various wound dressing products available. The cost of different treatments varies and the cost-effectiveness of each product has not been thoroughly evaluated. We compare two wound dressing protocols-alginate silver dressing (AlSD) and silver zinc sulfadiazine cream (AgZnSD) with regard to wound healing and cost-effectiveness.
Methods: Patients with grade III or IV sacral or trochanteric pressure ulcers were eligible for this prospective, randomized controlled trial. The patients were randomized to receive one of the two dressings for an eight-week period. The criteria of efficacy were based on the Pressure Ulcer Scale for Healing (PUSH) scoring tool. The cost of treatment was also assessed.
Results: Twenty patients (12 women and 8 men) were randomly assigned to receive either AlSD (n=10) or AgZnSD cream (n=10). The demographic data and wound characteristics were comparable in the two groups. The two groups showed no significant difference in the reduction of PUSH score, wound size, or volume of exudate. The tissue type score was significantly lower in the AlSD group (3.15±0.68-1.85±0.68 vs. 2.73±0.79-2.2±0.41; P=0.015). The cost of treatment was significantly lower in the AlSD group (377.17 vs. 467.74 USD, respectively; P<0.0001).
Conclusions: Alginate silver dressing could be effectively used in the treatment of grade III and IV pressure ulcers. It can improve wound tissue characteristics and is cost-effective.
Keywords: Calcium alginate; Cost effectiveness; Pressure ulcer.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
- Vanderwee K, Clark M, Dealey C, et al. Pressure ulcer prevalence in Europe: a pilot study. J Eval Clin Pract. 2007;13:227–235.
- Tannen A, Dassen T, Bours G, et al. A comparison of pressure ulcer prevalence: concerted data collection in the Netherlands and Germany. Int J Nurs Stud. 2004;41:607–612.
- Bennett G, Dealey C, Posnett J. The cost of pressure ulcers in the UK. Age Ageing. 2004;33:230–235.
- Xakellis GC, Frantz R. The cost of healing pressure ulcers across multiple health care settings. Adv Wound Care. 1996;9:18–22.
- Inman KJ, Sibbald WJ, Rutledge FS, et al. Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA. 1993;269:1139–1143.
- Reddy M, Gill SS, Kalkar SR, et al. Treatment of pressure ulcers: a systematic review. JAMA. 2008;300:2647–2662.
- Mooney EK, Lippitt C, Friedman J, et al. Silver dressings. Plast Reconstr Surg. 2006;117:666–669.
- Lansdown AB. Silver. I: Its antibacterial properties and mechanism of action. J Wound Care. 2002;11:125–130.
- Hermans MH. Silver-containing dressings and the need for evidence. Adv Skin Wound Care. 2007;20:166–173.
- Thomas S, McCubbin P. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care. 2003;12:305–308.
- Hooper SJ, Williams DW, Thomas DW, et al. An in vitro comparison of two silver-containing antimicrobial wound dressings. Ostomy Wound Manage. 2012;58:16–22.
- Percival SL, Slone W, Linton S, et al. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J. 2011;8:237–243.
- Ricci KE, Pittarello M, Cassino R, et al. AskinaCalgitrol Ag®: clinical use of an advanced ionic silver dressing. Acta Vulnologica. 2008;5:105–111.
- Addison D, Rennison TJ, Del Bono M. The antimicrobial properties of a silver alginate dressing for moderate to heavily exuding, wounds: 688. J Wound Ostomy Continence Nurs. 2005;32:S28.
- Opasanon S, Muangman P, Namviriyachote N. Clinical effectiveness of alginate silver dressing in outpatient management of partial-thickness burns. Int Wound J. 2010;7:467–471.
- Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
- Black J, Baharestani MM, Cuddigan J, et al. National Pressure Ulcer Advisory Panel's updated pressure ulcer staging system. Adv Skin Wound Care. 2007;20:269–274.
- Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis. 2002;35:1390–1396.
- Parish LC, Witkowski JA. The infected decubitus ulcer. Int J Dermatol. 1989;28:643–647.
- Fuller FW. The side effects of silver sulfadiazine. J Burn Care Res. 2009;30:464–470.
- Stotts NA, Rodeheaver GT, Thomas DR, et al. An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH) J Gerontol A Biol Sci Med Sci. 2001;56:M795–M799.
Source: PubMed